Emma Lees

Emma Lees currently serves as the Senior Vice President of Research and Early Development at Bristol Myers Squibb, where also holds the position of Head of Mechanisms of Cancer Resistance TRC and is Site Head at BMS Cambridge since September 2018. Prior to this, Emma Lees was the Vice President and Oncology Site Head at Jounce Therapeutics, Inc. from January 2017 to August 2018. Emma Lees has held multiple leadership roles at Novartis Institutes for BioMedical Research, including Vice President of Oncology Biotherapeutics and Vice President at Novartis, with responsibilities spanning from 2008 to 2017. Earlier experience includes a position as Senior Director of Discovery Research at DNAX/Schering Plough Biopharma from 1994 to 2008, as well as a Postdoctoral Fellow at Harvard Medical School from 1990 to 1994. Emma Lees earned a Doctor of Philosophy (PhD) in Biochemistry from the Imperial Cancer Research Fund in London and holds a BSc in Biochemistry from the University of Bristol.